Rick Doblin, Ph.D., founder of @MAPS dedicated activist + champion of healing, and all-around incredible human being, joins host Kaia Roman for an update on all things MDMA & FDA approval. Check out the full episode now!
https://t.co/wZWVu9QdRP
@RickDoblinPhD @KaiaRomanAuthor
Last week, we received monumental psychedelic news out of Australia. There, regulators decided to allow psilocybin-assisted therapy to treat depression, and MDMA-assisted therapy to treat PTSD (with proper diagnosis and a prescription). Are the US and Canada next?
Will Massachusetts decriminalize the possession of psychedelic drugs? Two state legislators recently filed a bill aimed at decriminalizing certain psychedelic substances in the state.
https://t.co/GOQx6a7u79
It came as a surprise to many when Australian regulators announced that medicines containing the psychedelic substances MDMA and psilocybin can soon be used there to treat PTSD and treatment-resistant depression, respectively.
https://t.co/d9JryECeQ4
Is this really about the depth and variety of clinical studies going after different health conditions, or is this just hype to accelerate the development of the psychedelic industry as a never-ending cure-all discovery? What are your thoughts?
https://t.co/qHTDnvhQ14
Apex Labs Ltd., an Iter Investment’s portfolio biopharma company developing psilocybin therapeutics, has been granted approval by Health Canada to begin its large take-home psilocybin clinical trial.
https://t.co/CoE7DlxUFB
We are delighted to be a media partner for @PsychedelicScience 2023. Register and be a part of the largest psychedelic gathering in history.
Use Women In Psychedelics discount code WPS15 for 15% off your registration.
@MAPSnews https://t.co/L2HU7x7Xbj
@Natalie_Lyla@MAPS Joined MAPS in 2014, where she co-developed their Health Equity program. Hear her predictions for how psychedelic legalization will roll out in the coming years and how psychedelic supporters can avoid the mistakes made with medical cannabis.
Check out the full episode!
@Natalie_Lyla , Global Impact Officer @Maps, is a woman on a mission! Driven from a young age to fight inequity toward marginalized communities, she helped legalize medical cannabis in New York through her work with the Drug Policy Alliance.
https://t.co/fY8rdu43Wh
Postpartum Depression #Psychedelic Treatment Studied In Reunion's Phase 1 Trial
Reunion Neuroscience has completed the data analysis for its Phase 1 clinical trial with its lead asset RE104, a 4-HO-DiPT prodrug treating #postpartum#depression.
https://t.co/dKsx2L83EK
$REUN
Congress Hops on #Psychedelics Juggernaut with a New Caucus
Two #Congressmen – Lou Correa (D-CA) and Jack Bergman (R-MI) – announced they formed The Psychedelics Advancing Clinical Treatments (PACT) #caucus focused on psychedelics research & therapies.
https://t.co/ylwmlHqUrV
Prince Harry Reveals He Used Psychedelics to Cope with #Grief
The Duke of Sussex' choice of phrase "clear the windshield" is symbolic of his journey with #psychedelics which allowed him to metaphorically clear away all sense of loss he was experiencing.
https://t.co/ckFRU2NVnP
Little is known about interest among women who experience elevated risk of mental health and substance use disorders. New study examined interest in receiving psychedelic-assisted therapy and socio-structural factors associated with interest among marginalized women.
Tune in for the who, what, when, where, why, how, and how often, as Victoria and Rome share their wisdom on microdosing + therapeutic support and resources. With so much interest in microdosing these days, this episode is a goldmine of information!
Meet Victoria Sterkin and Rome Shadanloo, the powerhouse founders of Mycology Psychology. If you want to know all about microdosing psilocybin to create lasting change, these ladies are the ones to listen to.
Check out the latest Psyched episode!
https://t.co/XbICbgoao1
According to the findings, women used MDMA more than men — about 35 percent of women preferred MDMA, followed by LSD, at more than 25 percent. Nearly 39 percent of men preferred LSD; 22 percent preferred psilocybin mushrooms.
When it comes to exploring the depths of the subconscious, women are more likely to take the plunge than men, says a 2020 Global Drug Survey.
https://t.co/dJz73O7YAz
Let’s do a quick tour of some of the latest announcements made by psychedelics companies over the past week. We promise you’ll be informed in less time than it takes to brew your coffee.
https://t.co/8YFlCsMIFn
Arizona would spend $30 million researching psychedelic mushrooms as a treatment for numerous medical conditions under a bipartisan proposal in the state capitol.
https://t.co/XakBaT0tsr
A U.S. Department of Veterans Affairs official says the agency is keeping a “very close eye” on psychedelics research and policy amid the growing reform movement.
https://t.co/h91yjsGgxy